2018 ´ëÇÑÁ¶Ç÷¸ð¼¼Æ÷À̽ÄÇÐȸ ±¹Á¦Çмú´ëȸ(9¿ù 1ÀÏ) : 2018-09-01±³À°ÀÏÀÚ : 2018-09-01
±³À°Àå¼Ò : ¹é½ºÄÚ Hall A, B
±³À°ÁÖÁ¦ :
2018 ´ëÇÑÁ¶Ç÷¸ð¼¼Æ÷À̽ÄÇÐȸ ±¹Á¦Çмú´ëȸ(9¿ù 1ÀÏ) ÁÖÃÖ±â°ü : ´ëÇÑÁ¶Ç÷¸ð¼¼Æ÷À̽ÄÇÐȸ
¿¬¶ôó : 02-516-6581
À̸ÞÀÏ :
bmt@kams.or.kr ±³À°Á¾·ù : ³»°ú, ¼Ò¾Æû¼Ò³â°ú, Áø´Ü°Ë»çÀÇÇаú
Âü¼®¿¹»óÀοø : 800¸í
Èñ¸ÁÆòÁ¡ : 3Á¡
Áö¿ª :
ºÎ»ê±¤¿ª½Ã±³À°½Ã°£ : 3 ½Ã°£ 0ºÐ
¼¼ºÎ¼ö°·á : 100,000¿ø
ºñ°í Á¤È¸¿ø(Àü¹®ÀÇ) £Ü100,000, ÁØȸ¿ø(°£È£»ç/Àü°øÀÇ/¿¬±¸¿ø) £Ü50,000- 5¿ù 31ÀÏ(¸ñ)±îÁö Á¤È¸¿ø(Àü¹®ÀÇ) £Ü150,000, ÁØȸ¿ø(°£È£»ç/Àü°øÀÇ/¿¬±¸¿ø) £Ü80,000- 7¿ù 31ÀÏ(È)±îÁö ÇöÀåµî·Ïºñ : Á¤È¸¿ø(Àü¹®ÀÇ) £Ü200,000, ÁØȸ¿ø(°£È£»ç/Àü°øÀÇ/¿¬±¸¿ø) £Ü100,000
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 09¿ù 01ÀÏ Hall A 09:00~09:30 T or NK-cell lymphoma ±è¼®Áø(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 09¿ù 01ÀÏ Hall A 09:30~10:00 Autologous stem cell transplantation for diffuse large B-cell lymphoma: Does it still work in the rituximab era Daryl Tan(Singapore)
±³À°½Ã°£ 09¿ù 01ÀÏ Hall A 10:00~10:30 The use of immune checkpoint inhibitor before and after allogeneic stem cell Franck Morschhauser(France)
±³À°½Ã°£ 09¿ù 01ÀÏ Hall B 10:50~11:30 Franck Morschhauser Mohamad Mohty(France)
±³À°½Ã°£ 09¿ù 01ÀÏ Hall B 11:30~11:55 Genetic prognostication and treatment ion ±è±âÇö(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 09¿ù 01ÀÏ Hall B 11:55~12:20 Novel drugs for post-transplantation failure ±èÁø¼®(¿¬¼¼ÀÇ´ë)